Nant Capital, LLC - Apr 27, 2021 Form 3 Insider Report for NantHealth, Inc. (NHIQ)

Role
10%+ Owner
Signature
/s/ Charles Kenworthy, Manager, Nant Capital, LLC
Stock symbol
NHIQ
Transactions as of
Apr 27, 2021
Transactions value $
$0
Form type
3
Date filed
8/30/2023, 05:24 PM
Next filing
Jul 5, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding NHIQ 4.50% Convertible Senior Notes due 2026 Apr 27, 2021 Common Stock 16.2M Direct F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Notes will be convertible at the option of the reporting persons at any time prior to the close of business on the business day immediately preceding the maturity date of the Notes. The Notes will be convertible into cash, shares of the issuer's common stock, or a combination thereof, at the issuer's election.
F2 The initial conversion rate of the 4.50% Convertible Senior Notes due 2026 (the "Notes") is 259.8753 shares of common stock per $1,000 principal amount of Notes (which is equivalent to an initial conversion price of approximately $3.85 per share), subject to adjustment pursuant to the terms of the Notes. The conversion rate and conversion price have not been adjusted to reflect the Reverse Split (as defined below).
F3 On December 15, 2022, the issuer effected a 1-for-15 reverse stock split (the "Reverse Stock Split") of its outstanding shares of common stock, par value $0.0001 per share ("Common Stock"). The numbers of shares reported on this Form 3 have not been adjusted to reflect the Reverse Split as it pertains to the number of shares of Common Stock that the reporting person beneficially owned as of the date that it became a reporting person.